Earnings results for IQVIA (NYSE:IQV)
IQVIA Holdings, Inc. is expected* to report earnings on 10/20/2020 before market open. The report will be for the fiscal Quarter ending Sep 2020. According to Zacks Investment Research, based on 8 analysts’ forecasts, the consensus EPS forecast for the quarter is $1.41. The reported EPS for the same quarter last year was $1.49.
IQVIA last issued its quarterly earnings results on July 22nd, 2020. The medical research company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.06 by $0.12. The firm had revenue of $2.52 billion for the quarter, compared to the consensus estimate of $2.41 billion. IQVIA has generated $5.94 earnings per share over the last year and currently has a price-to-earnings ratio of 241.3. IQVIA has confirmed that its next quarterly earnings report will be published on Tuesday, October 20th, 2020.
Analyst Opinion on IQVIA (NYSE:IQV)
17 Wall Street analysts have issued ratings and price targets for IQVIA in the last 12 months. Their average twelve-month price target is $165.00, predicting that the stock has a possible upside of 0.58%. The high price target for IQV is $200.00 and the low price target for IQV is $110.00. There are currently 1 hold rating and 16 buy ratings for the stock, resulting in a consensus rating of “Buy.”
IQVIA has received a consensus rating of Buy. The company’s average rating score is 2.94, and is based on 16 buy ratings, 1 hold rating, and no sell ratings. According to analysts’ consensus price target of $165.00, IQVIA has a forecasted upside of 0.6% from its current price of $164.05. IQVIA has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.
Dividend Strength: IQVIA (NYSE:IQV)
IQVIA does not currently pay a dividend. IQVIA does not have a long track record of dividend growth.
Insiders buying/selling: IQVIA (NYSE:IQV)
In the past three months, IQVIA insiders have sold 31,308.67% more of their company’s stock than they have bought. Specifically, they have bought $1,599,400.00 in company stock and sold $502,350,243.00 in company stock. Only 6.00% of the stock of IQVIA is held by insiders. 88.65% of the stock of IQVIA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of IQVIA (NYSE:IQV
Earnings for IQVIA are expected to grow by 23.60% in the coming year, from $5.72 to $7.07 per share. The P/E ratio of IQVIA is 241.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 19.66. The P/E ratio of IQVIA is 241.25, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 40.68. IQVIA has a PEG Ratio of 3.05. PEG Ratios above 1 indicate that a company could be overvalued. IQVIA has a P/B Ratio of 5.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here